Updated Presentation Time for DARA BioSciences At Collins Stewart Conference

RALEIGH, N.C., July 3, 2008 (PRIME NEWSWIRE) -- DARA BioSciences, Inc. will be presenting at 12:30 p.m. on Thursday, July 10, 2008, at the Fourth Annual Collins Stewart Growth Conference in New York City.

Interested parties can access a live audio web cast of the presentation at www.darabio.com. A replay of the presentation will be available at the same location.

About DARA BioSciences, Inc.

DARA BioSciences(tm), Inc. ("DARA") is a Raleigh, North Carolina-based development-stage pharmaceutical company that acquires and develops promising drug candidates. DARA focuses its therapeutic development efforts on small molecules from late preclinical development through phase 2 clinical trials. DARA has a portfolio of drug candidates for neuropathic pain, type 2 diabetes, and psoriasis. For more information, please contact the Company at 919-872-5578 or visit our web site at www.darabio.com.

CONTACT:  DARA BioSciences
          Lynn Morris, Sr. Mgr., Investor Relations & 
           Corporate Operations
          (919) 872-5578
        
          EVC Group
          Investors
          Dahlia Bailey
          (415) 896-6820

   _   _